PTPRN2
Receptor-type tyrosine-protein phosphatase N2
Also known as: IA-2beta, ICAAR, KIAA0387, phogrin, PTPR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92932
- Gene
- PTPRN2
- Ensembl
- ENSG00000155093
- Chromosome
- 7
- Canonical length
- 1015 aa
- Protein class
- Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a protein with sequence similarity to receptor-like protein tyrosine phosphatases. However, tyrosine phosphatase activity has not been experimentally validated for this protein. Studies of the rat ortholog suggest that the encoded protein may instead function as a phosphatidylinositol phosphatase with the ability to dephosphorylate phosphatidylinositol 3-phosphate and phosphatidylinositol 4,5-diphosphate, and this function may be involved in the regulation of insulin secretion. This protein has been identified as an autoantigen in insulin-dependent diabetes mellitus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
Canonical amino-acid sequenceUniProt
1015 residues, UniProt reviewed canonical sequence.
>Q92932|PTPRN2
1 MGPPLPLLLL LLLLLPPRVL PAAPSSVPRG RQLPGRLGCL LEEGLCGASE ACVNDGVFGR
61 CQKVPAMDFY RYEVSPVALQ RLRVALQKLS GTGFTWQDDY TQYVMDQELA DLPKTYLRRP
121 EASSPARPSK HSVGSERRYS REGGAALANA LRRHLPFLEA LSQAPASDVL ARTHTAQDRP
181 PAEGDDRFSE SILTYVAHTS ALTYPPGSRT QLREDLLPRT LGQLQPDELS PKVDSGVDRH
241 HLMAALSAYA AQRPPAPPGE GSLEPQYLLR APSRMPRPLL APAAPQKWPS PLGDSEDPSS
301 TGDGARIHTL LKDLQRQPAE VRGLSGLELD GMAELMAGLM QGVDHGVARG SPGRAALGES
361 GEQADGPKAT LRGDSFPDDG VQDDDDRLYQ EVHRLSATLG GLLQDHGSRL LPGALPFARP
421 LDMERKKSEH PESSLSSEEE TAGVENVKSQ TYSKDLLGQQ PHSEPGAAAF GELQNQMPGP
481 SKEEQSLPAG AQEALSDGLQ LEVQPSEEEA RGYIVTDRDP LRPEEGRRLV EDVARLLQVP
541 SSAFADVEVL GPAVTFKVSA NVQNVTTEDV EKATVDNKDK LEETSGLKIL QTGVGSKSKL
601 KFLPPQAEQE DSTKFIALTL VSLACILGVL LASGLIYCLR HSSQHRLKEK LSGLGGDPGA
661 DATAAYQELC RQRMATRPPD RPEGPHTSRI SSVSSQFSDG PIPSPSARSS ASSWSEEPVQ
721 SNMDISTGHM ILSYMEDHLK NKNRLEKEWE ALCAYQAEPN SSFVAQREEN VPKNRSLAVL
781 TYDHSRVLLK AENSHSHSDY INASPIMDHD PRNPAYIATQ GPLPATVADF WQMVWESGCV
841 VIVMLTPLAE NGVRQCYHYW PDEGSNLYHI YEVNLVSEHI WCEDFLVRSF YLKNLQTNET
901 RTVTQFHFLS WYDRGVPSSS RSLLDFRRKV NKCYRGRSCP IIVHCSDGAG RSGTYVLIDM
961 VLNKMAKGAK EIDIAATLEH LRDQRPGMVQ TKEQFEFALT AVAEEVNAIL KALPQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTPRN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 93 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 93 nTPM
- cerebral cortex: 60 nTPM
- basal ganglia: 57 nTPM
- hypothalamus: 50 nTPM
- amygdala: 44 nTPM
- hippocampal formation: 42 nTPM
Single-cell type
- gonadotrophs: 911 nCPM
- lactotrophs: 836 nCPM
- somatotrophs: 828 nCPM
- brain inhibitory neurons: 788 nCPM
- thyrotrophs: 733 nCPM
- other brain neurons: 692 nCPM
Immune cell
- neutrophil: 24 nTPM
- basophil: 14 nTPM
- T-reg: 5.3 nTPM
- naive B-cell: 4.2 nTPM
- memory B-cell: 3.5 nTPM
- eosinophil: 2.8 nTPM
Brain region
- cerebral cortex: 182 nTPM
- hippocampal formation: 150 nTPM
- basal ganglia: 139 nTPM
- amygdala: 129 nTPM
- hypothalamus: 128 nTPM
- white matter: 119 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTPRN2.
Disease | ImmuneIEDB
Conditions an epitope on PTPRN2 was assayed in.
- viral infectious disease B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against PTPRN2 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for PTPRN2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2.
1996 · Diabetes · RCR 1.5 · 68 citations - Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
1996 · Diabetes · RCR 1.2 · 50 citations - Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes.
1998 · Diabetes · RCR 1.1 · 51 citations - Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives.
2008 · Diabetologia · RCR 0.7 · 34 citations - Comparison of radioimmunoprecipitation with luciferase immunoprecipitation for autoantibodies to GAD65 and IA-2beta.
2010 · Diabetes Care · RCR 0.7 · 24 citations
Reference: B cellIEDB
1 publication
- Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR.
2002 · J Med Virol · RCR 1.2 · 61 citations
Reference: T cellIEDB
1 publication
- Peptides Derived From Insulin Granule Proteins Are Targeted by CD8+ T Cells Across MHC Class I Restrictions in Humans and NOD Mice.
2020 · Diabetes · RCR 1.9 · 45 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.06
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- insulin secretion involved in cellular response to glucose stimulus
- lipid metabolic process
- neurotransmitter secretion
- protein dephosphorylation
- regulation of secretion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tyrosine-specific protein phosphatase, PTPase domain
- Tyrosine-specific protein phosphatases domain
- Protein-tyrosine phosphatase, catalytic
- Protein-tyrosine phosphatase, active site
- Protein-tyrosine phosphatase receptor IA-2 ectodomain
- Protein-tyrosine phosphatase-like
- RESP18 domain
- Receptor-type tyrosine-protein phosphatase-like N/N2
- Protein-tyrosine phosphatase receptor IA-2, ectodomain superfamily
- Protein-tyrosine phosphatase
- Protein-tyrosine phosphatase receptor IA-2
- RESP18 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTPRN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTPRN2 as an antibody target. Whether an autoantibody or antibody against PTPRN2 could matter depends on whether native PTPRN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTPRN2 is annotated at the cell surface, where native PTPRN2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- This protein has been identified as an autoantigen in insulin-dependent diabetes mellitus.
Loading the interactive Seroatlas protein explorer...